日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Papaverine Targets STAT Signaling: A Dual-Action Therapy Option Against SARS-CoV-2.

罂粟碱靶向 STAT 信号通路:对抗 SARS-CoV-2 的双重作用疗法选择

Reus Philipp, Torbica Emma, Rothenburger Tamara, Bechtel Marco, Kandler Joshua, Ciesek Sandra, Gribbon Philip, Kannt Aimo, Cinatl Jindrich, Bojkova Denisa

Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection

布洛芬、氟比洛芬、依托考昔或对乙酰氨基酚在体外或小鼠体内均不影响ACE2的表达和活性,也不会加剧体外SARS-CoV-2感染。

de Bruin, Natasja; Schneider, Ann-Kathrin; Reus, Philipp; Talmon, Sonja; Ciesek, Sandra; Bojkova, Denisa; Cinatl, Jindrich; Lodhi, Imran; Charlesworth, Bruce; Sinclair, Simon; Pennick, Graham; Laughey, William F; Gribbon, Philip; Kannt, Aimo; Schiffmann, Susanne

Characterization of ACE Inhibitors and AT(1)R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model

利用Caco-2细胞模型表征ACE抑制剂和AT(1)R拮抗剂对ACE2表达和SARS-CoV-2感染的影响

Reus, Philipp; Schneider, Ann-Kathrin; Ulshöfer, Thomas; Henke, Marina; Bojkova, Denisa; Cinatl, Jindrich; Ciesek, Sandra; Geisslinger, Gerd; Laux, Volker; Grättinger, Mira; Gribbon, Philip; Schiffmann, Susanne